Research output per year
Research output per year
Fingerprint
Dive into the research topics where Willem H. van Harten is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
-
Analysing the attributes of Comprehensive Cancer Centres and Cancer Centres across Europe to identify key hallmarks
Kehrloesser, S., Oberst, S., Westerhuis, W., Wendler, A., Wind, A., Blaauwgeers, H., Burrion, J. B., Nagy, P., Saeter, G., Gustafsson, E., De Paoli, P., Lovey, J., Lombardo, C., Philip, T., de Valeriola, D., Docter, M., Boomsma, F., Saghatchian, M., Svoboda, M., Philip, I. & 5 others, , May 2021, In: Molecular oncology. 15, 5, p. 1277-1288 12 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile1 Citation (Scopus)1 Downloads (Pure) -
A revolving research fund to study efficient use of expensive drugs: big wheels keep on turning
van Ommen-Nijhof, A., Retèl, V. P., van den Heuvel, M., Jager, A., van Harten, W. H. & Sonke, G. S., Oct 2021, In: Annals of oncology. 32, 10, p. 1212-1215 4 p.Research output: Contribution to journal › Editorial › Academic › peer-review
-
Cost-Effectiveness of Surgery Versus Organ Preservation in Advanced Laryngeal Cancer
Beck, A. J. C. C., van Harten, W. H., van den Brekel, M. W. M., Navran, A. & Retèl, V. P., 1 Feb 2021, In: Laryngoscope. 131, 2, p. E509-E517Research output: Contribution to journal › Article › Academic › peer-review
-
Determinants of adherence to physical cancer rehabilitation guidelines among cancer patients and cancer centers: a cross-sectional observational study
IJsbrandy, C., Ottevanger, P. B., Gerritsen, W. R., van Harten, W. H. & Hermens, R. P. M. G., 1 Feb 2021, In: Journal of cancer survivorship. 15, p. 163-177 15 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile2 Citations (Scopus)15 Downloads (Pure) -
Early Cost Effectiveness of Whole-Genome Sequencing as a Clinical Diagnostic Test for Patients with Inoperable Stage IIIB,C/IV Non-squamous Non-small-Cell Lung Cancer
Simons, M. J. H. G., Retèl, V. P., Ramaekers, B. L. T., Butter, R., Mankor, J. M., Paats, M. S., Aerts, J. G. J. V., Mfumbilwa, Z. A., Roepman, P., Coupé, V. M. H., Uyl-de Groot, C. A., van Harten, W. H. & Joore, M. A., 18 Aug 2021, (E-pub ahead of print/First online) In: PharmacoEconomics.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile
Activities
- 1 Oral presentation
-
Alliantie Regionale Topzorg
Willem H. van Harten (Speaker)
4 Mar 2015Activity: Talk or presentation › Oral presentation